Stay updated on rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial page.

Latest updates to the rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial page
- Check2 days agoChange DetectedThe page displays the completed Phase 3 study record for rFVIIIFc in previously untreated males with severe hemophilia A, including its design, outcomes, locations, and study documents.SummaryDifference76%

- Check9 days agoChange DetectedThe footer now identifies the site revision as v3.8.0 instead of v3.7.2; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA general NIH website-transition notice appears above the 403 error page. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check37 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now shows a 403 Forbidden error, blocking access to the study record content. What was a detailed listing of the study’s overview, documents, and locations is replaced by an error page, indicating that the study information is not accessible at this time.SummaryDifference17%

- Check58 days agoChange DetectedThe page footer now shows Revision: v3.7.0, replacing the previous v3.6.6. This indicates a new version of the page template was deployed.SummaryDifference0.0%

Stay in the know with updates to rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial page.